Rasmus Steen Pedersen
Institute of Public Health
Clinical Pharmacology
University of Southern Denmark
Odense
Denmark
Name/email consistency: high
- Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations. Pedersen, R.S., Brasch-Andersen, C., Sim, S.C., Bergmann, T.K., Halling, J., Petersen, M.S., Weihe, P., Edvardsen, H., Kristensen, V.N., Brøsen, K., Ingelman-Sundberg, M. Eur. J. Clin. Pharmacol. (2010)
- Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers. Pedersen, R.S., Damkier, P., Brøsen, K. Eur. J. Clin. Pharmacol. (2006)
- The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects. Pedersen, R.S., Damkier, P., Brosen, K. Br. J. Clin. Pharmacol (2006)
- Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study. Pedersen, R.S., Damkier, P., Brosen, K. Clin. Pharmacol. Ther. (2005)
- Cytochrome P4502C9 (CYP2C9) genotypes in a Nordic population in Denmark. Pedersen, R.S., Verstuyft, C., Becquemont, L., Jaillon, P., Brøsen, K. Basic Clin. Pharmacol. Toxicol. (2004)